22. July 2016

Andrea Engel, PhD, Head of Particle Formulation Laboratory; Anne Benedikt, PhD, Head of Biopharmaceutical Laboratory; and Hans Baer, MSc, Senior Project Manager, all of Evonik, explain how their recently introduced new modular platform technology for improving the oral bioavailability of peptides may offer a feasible solution to the problem of compliance with peptide drugs. These can be highly beneficial for conditions such as diabetes, oncology and metabolic disorders but the fact they have to...